Novacyt

Primerdesign Launches Real-time PCR Workflow for Onsite Detection of Norovirus in Oysters

Home | News | Press Releases | Primerdesign Launches Real-time PCR Workflow for Onsite Detection of Norovirus in Oysters
  • genesig Easy_oys Detection Kit offers rapid and reliable qPCR workflow to quantify Norovirus GI and GII pathogens in oyster tissue 
  • Onsite analysis helps ensure shellfish quality and safety across the production line, reducing public health risk 
  • Developed in collaboration with oyster farmers and Shellfish Association of Great Britain 
  • Primerdesign to present new developments in Norovirus testing at ACIG: Aquaculture innovation and supply chain resilience (25 June 2024) 

Eastleigh, UK, 25 June 2024: Primerdesign (part of the Novacyt Group), a company focussed on the design, manufacture, validation and supply of real-time PCR kits and reagents, today launched the genesig® Easy_oys Detection Kit for Norovirus in oysters. The quantitative PCR (qPCR) assay enables rapid and reliable detection of genogroup (G)I and GII Norovirus pathogens in oyster tissue. The user-friendly workflow offers a cost-effective solution that can be used on site to identify the contamination points across the production line, helping to reduce public health risk and minimise shellfish farm closures. 

Norovirus is a major cause of viral gastroenteritis and foodborne transmission is responsible for an estimated 16% of cases in the UK*. Human sewage discharge around oyster beds results in bio-accumulation of the virus in their digestive glands, with more than 500 genome copies/gram of Norovirus GI / GII presenting a major risk of infection when consumed by humans. 

There is a growing need for methods to detect and quantify viruses in bivalve shellfish to control and risk manage potential outbreaks and spread. The Centre for Environment, Fisheries and Aquaculture Science (Cefas) in England and the Marine Institute in the Republic of Ireland, the only ISO 15216-accredited laboratories for PCR quantification of Norovirus in oysters in the British Isles, currently perform a limited number of tests from each grower due to resource constraints. This places food safety in jeopardy and farms at risk of closure if a Norovirus outbreak is linked to their oysters. 

Quantitative PCR methods offer a fast and accurate means of screening water and food. The genesig Easy_oys Norovirus kit is a qPCR assay optimised for the quantitative detection of Norovirus GI and GII genomes in the digestive tissue of oysters. The highly sensitive kit demonstrated detection of both GI and GII down to 500 copies/gram, making it a suitable risk management tool to ensure that oysters with high infection risk are detected. The kit includes all the reagents needed to conduct viral testing in line with the ISO 15216 guidelines, without any prior lab experience. The complete testing workflow, including the exisgMag extraction kit, genesig Easy_oys Norovirus kit, and the genesig q16 instrument, delivers results within four hours. It was developed in collaboration with oyster farmers and the Shellfish Association of Great Britain, providing them with an easy-to-use and accessible tool to rapidly assess the food safety risk and give them confidence in the quality of their oysters.

Related Articles

Yourgene Health and Genetix Launch First Local Non-invasive Prenatal Testing Service in Colombia

3 October 2024

Yourgene Health and Genetix Launch First Local Non-invasive Prenatal Testing Service in Colombia Genetix will utilise Yourgene Health’s IONA Nx NIPT Workflow to deliver first NIPT service in region...
Read more Read more

Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries

17 November 2023

Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries Yourgene’s LightBench® instrument offers precise and accurate target enrichment of PacBio HiFi...
Read more Read more

Yourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco

9 November 2023

Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents Manchester, UK, and Rabat, MOROCCO,...
Read more Read more

IVDR certification achieved for DPYD genotyping assay – First product of its kind to conform with new IVDR requirements

7 November 2023

IVDR certification achieved for DPYD genotyping assay First product of its kind to conform with new IVDR requirements Yourgene Health (part of the Novacyt group), an international specialist in...
Read more Read more

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

5 September 2023

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and...
Read more Read more